EUDA Health Holdings Limited EUDA
17.86
1.44
8.77%
as of 25 Sep
- Market cap
- $49.2M
- P/E
- 0.0×
Follow EUDA
| Dec '17 | Jul '21 | Dec '21 | Jul '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 589.95 | 86.63 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | 0.00 | 4,235.89 | (6,519.24) | (236.41) | (1,392.17) | (1,530.24) | (817.99) |
P/B ratio |
— | 0.00 | 3,133.52 | 26.78 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | 0.00 | 0.00 | 26.78 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | 0.00 | 0.00 | (1,701.15) | (142.60) | (266.28) | (569.91) | (222.78) |
EV/FCF |
— | 0.00 | 0.00 | (1,701.15) | (142.60) | (266.28) | (569.91) | (220.59) |
Quick Ratio |
— | 0.58 | 0.59 | 0.85 | 0.03 | 0.05 | 0.10 | 0.12 |
Current Ratio |
— | 0.60 | 0.60 | 0.86 | 0.86 | 0.08 | 0.18 | 0.18 |
Net Debt/EBITDA |
— | (0.28) | (0.18) | (0.57) | 0.04 | (0.15) | (0.04) | (0.80) |
Debt/Assets |
0.00% | 5.78% | 4.64% | 15.13% | 0.86% | 60.13% | 58.30% | 126.23% |
Debt/Equity |
— | 0.89 | 0.62 | (1.10) | (0.06) | (0.11) | (0.38) | (0.51) |
Asset Turnover |
— | 2.64 | 1.32 | 0.59 | 0.15 | 0.28 | 2.67 | 4.00 |
Operating CF/Net income |
— | 0.51 | 0.51 | 0.06 | 0.06 | 0.29 | 0.13 | 0.88 |
Capex/Depreciation |
— | 0.00 | (0.01) | 0.00 | (0.15) | 0.00 | (2.74) | (0.54) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 0.00% | 154.25% | 1,704.16% | 708.19% | 182.72% | 305.49% | 81.08% | |
| — | 21.62% | 10.81% | (148.00%) | (97.09%) | (74.53%) | (1,020.99%) | (162.42%) | |
ROIC |
— | 0.00% | (98.27%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | (30.86%) | (29.76%) | 626.79% | 612.46% | 125.69% | 466.67% | 59.52% |
Average Days of Receivables |
— | 141.52 | 141.62 | 890.65 | 18.96 | 23.56 | 15.50 | 17.89 |
Research and Development Expense of Revenue |
— | 1.23% | 1.23% | 0.17% | 0.46% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 50.67% | 50.67% | 92.03% | 317.46% | 129.59% | 83.31% | 79.66% |
Intangible Assets out of Total Assets |
0.00 | 0.16 | 0.16 | 0.00 | 0.00 | 0.00 | 0.20 | 0.09 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | 0.00 | 0.00 | 0.04 | (0.01) | (0.01) | 0.00 | 0.00 |
Graham Number |
— | 0.00 | 0.00 | 7.49 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
— | (0.01%) | (0.01%) | 0.17% | 1.15% | (9.05%) | (3.07%) | (5.95%) |
Free Cash Flow Yield |
— | 0.00% | 0.00% | (0.06%) | (0.70%) | (0.38%) | (0.18%) | (0.45%) |
Revenue per Share |
— | 1.14 | 22.79 | 0.82 | 6.26 | 3.24 | 2.47 | 3.65 |
Operating CF per Share |
— | 0.05 | 0.96 | (0.13) | (2.54) | (2.55) | (1.25) | (1.30) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | (0.03) | 0.00 | (0.07) | (0.06) |
Free Cash Flow per Share |
— | 0.05 | 0.96 | (0.13) | (2.57) | (2.55) | (1.33) | (1.35) |
Cash per Share |
— | 0.02 | 0.41 | 0.07 | 1.16 | 0.17 | 0.15 | 0.18 |
Shareholders Equity per Share |
— | 0.06 | 1.30 | (0.29) | (5.83) | (6.53) | (1.58) | (2.28) |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.06 | 1.30 | (0.29) | (5.83) | (6.53) | (1.58) | (2.28) |
Free Cash Flow |
— | 0.44 | 0.44 | (1.53) | (1.54) | (2.92) | (2.15) | (2.53) |
Working Capital |
— | (2.96) | (2.96) | (4.09) | (4.09) | (7.99) | (3.38) | (4.80) |
Capital Expenditures |
— | 0.00 | 0.00 | (0.02) | (0.02) | — | (0.12) | (0.10) |
Net Current Asset Value |
— | (3.05) | (3.05) | (4.11) | (4.11) | (8.07) | (3.51) | (4.94) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 |
Net Profit Margin |
— | 8.20% | 8.20% | (252.87%) | (661.06%) | (270.86%) | (382.88%) | (40.66%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 1.59 | 3.47 | 1.99 | 3.84 | 0.73 | 0.48 | 1.42 |
Cash ROIC |
— | 24.09% | 33.33% | (144.52%) | 60.20% | 44.96% | 157.83% | 146.04% |
Accounts Receivable Turnover |
— | 0.00 | 2.58 | 0.70 | 0.31 | 17.05 | 19.59 | 27.04 |
Accounts Payable Turnover |
— | 0.00 | 2.23 | 2.91 | 1.77 | 3.50 | 11.15 | 5.53 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 58.08 |
Average Days of Payables |
— | 163.32 | 163.32 | 92.03 | 206.25 | 0.17 | 65.31 | 76.69 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.49 | 0.27 |
Average Receivables |
— | — | 4.09 | 14.05 | 12.10 | 0.22 | 0.20 | 0.25 |
Average Payables |
— | — | 2.82 | 2.23 | 1.64 | 0.82 | 0.29 | 0.69 |
Average Inventory |
— | — | — | — | — | — | — | 0.07 |
Average Assets |
— | 4.00 | 8.00 | 16.81 | 25.63 | 13.47 | 1.50 | 1.71 |
Average Common Equity |
— | — | 0.56 | (1.46) | (3.51) | (5.49) | (5.03) | (3.42) |
Columns are period end dates